169 related articles for article (PubMed ID: 24836545)
1. Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant.
Kempf W; Kazakov DV; Rütten A; Rupec RA; Talarcik P; Ballová V; Kerl K; Dummer R; Lautenschlager S; Zimmermann DR; Tinguely M
J Am Acad Dermatol; 2014 Sep; 71(3):548-54. PubMed ID: 24836545
[TBL] [Abstract][Full Text] [Related]
2. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases.
Magro CM; Nash JW; Werling RW; Porcu P; Crowson N
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):7-11. PubMed ID: 16540723
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 expression in cutaneous B-cell lymphoma.
Çetinözman F; Koens L; Jansen PM; Willemze R
J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
[TBL] [Abstract][Full Text] [Related]
5. Microvillous lymphomas are B-cell neoplasms that frequently express CD56.
Hammer RD; Vnencak-Jones CL; Manning SS; Glick AD; Kinney MC
Mod Pathol; 1998 Mar; 11(3):239-46. PubMed ID: 9521469
[TBL] [Abstract][Full Text] [Related]
6. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
[TBL] [Abstract][Full Text] [Related]
8. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
[TBL] [Abstract][Full Text] [Related]
9. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
[TBL] [Abstract][Full Text] [Related]
11. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
12. C-KIT expression in primary cutaneous T-cell lymphomas.
Brauns TC; Schultewolter T; Dissemond J; Maschke J; Goos M
J Cutan Pathol; 2004 Oct; 31(9):577-82. PubMed ID: 15330987
[TBL] [Abstract][Full Text] [Related]
13. CD30 expression in cutaneous B-cell lymphomas.
Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
[TBL] [Abstract][Full Text] [Related]
14. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
17. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
18. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of CD30 Expression in Aggressive B-Cell Lymphomas.
Malysz J; Erdman P; Klapper J; Zhu J; Creer M; Bayerl MG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):429-33. PubMed ID: 27521276
[TBL] [Abstract][Full Text] [Related]
20. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
